within Pharmacolibrary.Drugs.R_RespiratorySystem.R06A_AntihistaminesForSystemicUse.R06AB05_Pheniramine;

model Pheniramine
  extends Pharmacolibrary.Drugs.ATC.R.R06AB05;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>R06AB05</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Pheniramine is a first-generation antihistamine belonging to the alkylamine class, commonly used for the symptomatic relief of allergic conditions such as hay fever, urticaria, and rhinitis. It has anticholinergic and sedative properties. While once widely used, its application is now limited in some regions due to the sedative side effects, though it remains available both as over-the-counter and prescription medication in various countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for a healthy adult population after oral administration, as no direct referenced publication with full PK modeling found for pheniramine.</p><h4>References</h4><ol><li><p>Witte, PU, et al., &amp; Hajdú, P (1985). Pharmacokinetics of pheniramine (Avil) and metabolites in healthy subjects after oral and intravenous administration. <i>International journal of clinical pharmacology, therapy, and toxicology</i> 23(1) 59–62. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/3988394/\">https://pubmed.ncbi.nlm.nih.gov/3988394</a></p></li><li><p>Pathirana, S, et al., &amp; Thompson, GA (2018). Brompheniramine and Chlorpheniramine Pharmacokinetics Following Single-Dose Oral Administration in Children Aged 2 to 17 Years. <i>Journal of clinical pharmacology</i> 58(4) 494–503. DOI:<a href=\"https://doi.org/10.1002/jcph.1037\">10.1002/jcph.1037</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/29136286/\">https://pubmed.ncbi.nlm.nih.gov/29136286</a></p></li><li><p>Kuroda, T, et al., &amp; Hariu, K (2013). Pharmacokinetics and pharmacodynamics of d-chlorpheniramine following intravenous and oral administration in healthy Thoroughbred horses. <i>Veterinary journal (London, England : 1997)</i> 197(2) 433–437. DOI:<a href=\"https://doi.org/10.1016/j.tvjl.2013.02.003\">10.1016/j.tvjl.2013.02.003</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/23489843/\">https://pubmed.ncbi.nlm.nih.gov/23489843</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Pheniramine;
